Adiponectin abates atherosclerosis by reducing oxidative stress

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 1792-1800

  Wang, Xuemei ^a   Pu, Hongwei ^a   Ma, Chuang ^a   Jiang, Tao ^a   Wei, Qin ^a   Duan, Mingjun ^a   Zhang, Chun ^a   Shou, X ^a   Su, Lipin ^a   Zhang, Jianlong ^a   Yang, Yining ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Atherosclerosis; Nitric oxide synthase type III; Oxidative stress; Superoxide dismutase

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; MESSENGER RNA; PRIMER DNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; EAL TIME POLYMERASE CHAIN REACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; MALE; MOUSE; MRNA EXPRESSION ASSAY; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADIPONECTIN; ANIMALS; ATHEROSCLEROSIS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; MALE; MICE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84908142654     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.892299     Document Type: Article

References (52)

1. Lehrke M, Lebherz C: AAV-Mediated Gene Therapy for Atherosclerosis. Curr Atheroscler Rep, 2014; 16(9): 434
2. Blum A: HMG-CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells-New mechanistic insights of atherosclerosis. Biofactors, 2014; 40(3): 295–302
3. Montagnana M, Danese E, Lippi G: Genetic risk factors of atherothrombosis. Pol Arch Med Wewn, 2014 [Epub ahead of print]
4. Jamkhande PG, Chandak PG, Dhawale SC et al: Therapeutic approaches to drug targets in atherosclerosis. Saudi Pharm J, 2014; 22(3): 179–90
5. Suzuki M, Minami A, Nakanishi A et al: Atherosclerosis and tumor suppressor molecules. Int J Mol Med, 2014; 34(4): 934–40
6. Sessa R, Pietro MD, Filardo S et al. Infectious burden and atherosclerosis: A clinical issue. World J Clin Cases. 2014 16;2(7): 240-9.
7. Dagli N, Ozturk U, Karaca I et al: Adiponectin levels in coronary artery ectasia. Heart Vessels, 2009; 24(2): 84–89
8. Lehrke M, Greif M, Broedl UC et al: MMP-1 serum levels predict coronary atherosclerosis in humans. Cardiovasc Diabetol, 2009; 8: 50
9. Ekmekci H, Ekmekci OB: The role of adiponectin in atherosclerosis and thrombosis. Clin Appl Thromb Hemost, 2006; 12(2): 163–68
10. Ohashi K, Shibata R, Murohara T et al: Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab, 2014; 25(7): 348–55
11. Nakatsuji H, Kishida K, Sekimoto R et al: Accumulation of adiponectin in inflamed adipose tissues of obese mice. Metabolism, 2014; 63(4): 542–53
12. Van Stijn CM, Kim J, Barish GD et al: Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One, 2014; 9(1): e86404
13. Hayashino Y, Jackson JL, Hirata T et al: Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomizedcontrolled trials. Metabolism, 2014; 63(3): 431–40
14. Komura N, Maeda N, Mori T et al: Adiponectin protein exists in aortic endothelial cells. PLoS One, 2013; 8(8): e71271
15. Takeuchi S, Wada K, Uozumi Y et al: Adiponectin receptor 1 expression is associated with carotid plaque stability. Neurol India, 2013; 61(3): 249–53
16. Adya R, Tan BK, Chen J et al: Protective actions of globular and full-length adiponectin on human endothelial cells: novel insights into adiponectininduced angiogenesis. J Vasc Res, 2012; 49(6): 534–43
17. Cheraghi N, Dai H, Raghuveer G: Vitamin D deficiency is associated with atherosclerosis-promoting risk factor clustering but not vascular damage in children. Med Sci Monit, 2012; 18(12): CR687–92
18. Motawi T, Shaker O, Taha N et al: Genetic variations in E-selectin and ICAM- 1: relation to atherosclerosis. Med Sci Monit, 2012; 18(6): CR381–89
19. Yang Y, Cui Y, Peng DQ: The role of monocyte phenotype switching in periprocedural myocardial injury and its involvement in statin therapy. Med Sci Monit, 2013; 19: 1006–12
20. Chen X, Zhang H, McAfee S et al: The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice. Am J Physiol Heart Circ Physiol, 2010; 299: H605–12
21. Drummond GR, Sobey CG: Endothelial NADPH oxidizes: which NOX to target in vascular disease? Trends Endocrinol Metab, 2014; pii: S1043-2760(14)00123-4
22. Shaw A, Doherty MK, Mutch NJ et al: Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications? Biochem Soc Trans, 2014; 42(4): 928–33
23. Lee S, Zhang H, Chen J et al: Adiponectin abates diabetes-induced endothelial dysfunction by suppressing oxidative stress, adhesion molecules, and inflammation in type 2 diabetic mice. Am J Physiol Heart Circ Physiol, 2012; 303(1): H106–15
24. Okamoto Y, Kihara S, Ouchi N et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2002; 106(22): 2767–70
25. Sasaguri Y, Tanimoto A: Role of macrophage-derived histamine in atherosclerosis – chronic participation in the inflammatory response. J Atheroscler Thromb, 2004; 11(3): 122–30
26. Dessein PH, Tsang L, Solomon A et al: Adiponectin and atherosclerosis in rheumatoid arthritis. Mediators Inflamm, 2014; 2014: 358949
27. Fayad R, Pini M, Sennello JA et al: Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology, 2007; 132(2): 601–14
28. Ohman MK, Shen Y, Obimba CI et al: Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation, 2008; 117(6): 798–805
29. Nishida M, Moriyama T, Ishii K et al: Effects of IL-6, adiponectin, CRP and metabolic syndrome on subclinical atherosclerosis. Clin Chim Acta, 2007; 384(1–2): 99–104
30. Li L, Wu LL: Adiponectin and interleukin-6 in inflammation-associated disease. Vitam Horm, 2012; 90: 375–95
31. Ouchi N, Kihara S, Arita Y et al: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation, 2000; 102(11): 1296–301
32. Chen H, Montagnani M, Funahashi T et al: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem, 2003; 278(45): 45021–26
33. Nawrocki AR, Hofmann SM, Teupser D et al: Lack of association between adiponectin levels and atherosclerosis in mice. Arterioscler Thromb Vasc Biol, 2010; 30(6): 1159–65
34. Lee S, Park Y, Dellsperger KC et al: Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. Am J Physiol Heart Circ Physiol, 2011; 301(2): H306–14
35. Lee S, Park Y, Zuidema MY et al: Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol, 2011; 3(1): 18–24
36. Cai XJ, Li CJ, Chen L et al: A hypothesis: adiponectin mediates anti-atherosclerosis via adventitia-AMPK-iNOS pathway. Med Hypotheses, 2008; 70(5): 1044–47
37. Motoshima H, Wu X, Mahadev K et al: Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun, 2004; 315(2): 264–71
38. Parker-Duffen JL, Nakamura K, Silver M et al: T-cadherin is essential for adiponectin- mediated revascularization. J Biol Chem, 2013; 288(34): 24886–97
39. Owens CD, Kim JM, Hevelone ND et al: Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein. J Vasc Surg, 2010; 51(5): 1152–59
40. Huang SS, Huang PH, Chen YH et al: Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction. J Atheroscler Thromb, 2010; 17(3): 295–303
41. Kondo M, Shibata R, Miura R et al: Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthase. J Biol Chem, 2009; 284(3): 1718–24
42. Ishii M, Shibata R, Kondo K et al: Vildagliptin stimulates endothelial cell network formation and ischemia-induced revascularization via an endothelial nitric oxide synthase-dependent mechanism. J Biol Chem, 2014; pii: jbc.M114.557835
43. Bharrhan S, Chopra K, Arora SK et al: Down-regulation of NF-kB signalling by polyphenolic compounds prevents endotoxin-induced liver injury in a rat model. Innate Immun, 2012; 18(1): 70–79
44. Hulsmans M, Geeraert B, Arnould T et al: PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese,insulin-resistant mice depends on adiponectin-induced Irak3 expression. PLoS One, 2013; 8(4): e62253
45. Mierzecki A, Kłoda K, Bukowska H et al: Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors. Med Sci Monit, 2013; 19: 733–39
46. Yamauchi T, Kamon J, Waki H et al: Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem, 2003; 278: 2461–68
47. Tian L, Luo N, Klein RL et al: Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis, 2009; 202(1): 152–61
48. Luo N, Liu J, Chung BH et al: Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes, 2010; 59(4): 791–99
49. Yoshida S, Fuster JJ, Walsh K: Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis, 2014; 235: 339–46
50. Nigro E, Scudiero O, Monaco ML et al: New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases. Biomed Res Int, 2014; 2014: 658913
51. Guo R, Li W, Liu B et al: Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monit Basic Res, 2014; 20: 82–92
52. Karwowski W, Naumnik B, Szczepański M et al: The mechanism of vascular calcification – a systematic review. Med Sci Monit, 2012; 18(1): RA1–11